Skip to Main Content

Paper Details

Dosing Variation at Initiation of Adalimumab and Etanercept and Clinical Outcomes in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study.
Arthritis Care and Research
1
2023
Adalimumab, Arthritis, Childhood Arthritis, Etanercept, JIA, Juvenile Arthritis, Juvenile Idiopathic Arthritis, Participants, TNF, adalimumab, etanercept, juvenile idiopathic arthritis, tumor necrosis factor
Author NameAffiliation
Peter ShraderDuke University
Brian M FeldmanThe Hospital for Sick Children and University of Toronto
  • 1 - 2

Datasets

Release 1.2